← Back to Search

Behavioural Intervention

Alcohol for Alcohol Consumption

Phase < 1
Waitlist Available
Research Sponsored by Carnegie Mellon University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
21 to 29 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-month follow-up
Awards & highlights

Study Summary

This trial looks at what might cause alcohol problems in young adults in the future.

Who is the study for?
This study is for young adults aged 21 to 29 who currently drink alcohol and own a smartphone. It's designed to help understand risk factors that may lead to alcohol problems.Check my eligibility
What is being tested?
The trial is testing the effects of consuming alcohol versus a placebo on behavior. Participants will be randomly assigned to receive either alcoholic beverages or non-alcoholic lookalikes in order to compare responses.See study design
What are the potential side effects?
Since this trial involves the consumption of alcohol, potential side effects include typical reactions such as impaired coordination, slurred speech, mood changes, and possibly hangover symptoms like headache and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 29 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Alcohol Use Disorder Symptoms at 12-months
Change from Baseline Alcohol Use at 12-months
Secondary outcome measures
Alcohol Use
Mood
Social Bonding
+1 more

Side effects data

From 2017 Phase 2 trial • 17 Patients • NCT01779024
59%
Increased Appetite
41%
Somnolence
35%
Euphoric mood
29%
Fatigue
12%
Memory impairment
12%
Hyperhidrosis
12%
Dizziness
12%
Nausea
6%
Feeling hot
6%
Flushing
6%
Headache
6%
Decreased appetite
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ghrelin
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Alcohol BeverageExperimental Treatment1 Intervention
Moderate dose of alcohol (target BAC .08%)
Group II: Placebo BeveragePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol
2008
Completed Phase 3
~2000

Find a Location

Who is running the clinical trial?

Carnegie Mellon UniversityLead Sponsor
76 Previous Clinical Trials
539,148 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,361,729 Total Patients Enrolled
University of PittsburghOTHER
1,719 Previous Clinical Trials
16,341,559 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project accept adults as participants?

"This research study seeks individuals that are between 21 and 29 years old."

Answered by AI

What are the main goals of this clinical research endeavor?

"The primary aim of this medical study, which will be monitored over a year-long period, is to measure the difference between baseline and post-treatment Alcohol Use Disorder Symptoms. Further objectives include assessing Mood (an 8-point scale that records felt emotions), Social Bonding (12 items scored from 1-9 indicating level of bonding) and Alcohol Usage (amount of standard drinks consumed)."

Answered by AI

What is the total enrolment of participants in this trial?

"Affirmative, clinicaltrials.gov data indicates that recruitment for this trial is still in progress. It was initially listed on February 13th 2018 and most recently updated on July 25th 2022 with a goal of 400 participants from one centralised location."

Answered by AI

What maladies can be ameliorated by the consumption of ethanol?

"Alcohol is a common intervention for obstructive hypertrophic cardiomyopathy, and has also been used to treat communicable diseases, ethylene glycol poisoning, as well as skin disinfection therapy."

Answered by AI

Are additional participants being accepted for the trial?

"The data hosted on clinicaltrials.gov explicitly indicates that this research trial, which commenced in February 2018, is actively seeking participants. The latest update was issued at the end of July 2022."

Answered by AI

What criteria must a person meet to qualify for enrollment in this clinical trial?

"This clinical trial seeks 400 participants, aged 21 to 29 years old, who drink alcohol and own a smartphone. These criteria must be met in order for someone to qualify as an enrollee."

Answered by AI
~109 spots leftby Apr 2025